Indian business news
Sunday, June 21, 2020
Cipla Gets Regulatory Nod To Make COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
from NDTV Profit - Latest https://ift.tt/2NjBVTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment